Study of TQB2450 in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck（R/M SCCHN）

NCT03855384 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

334

Enrollment

INDUSTRY

Sponsor class

Conditions

Squamous Cell Carcinoma of the Head and Neck

Interventions

DRUG: TQB2450+cisplatin or carboplatin + 5-Fluorouracil (5-FU)
DRUG: placebo+cisplatin or carboplatin + 5-Fluorouracil (5-FU)

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.